CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test
FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN DIEGO, CA / ACCESSWIRE /...
Diagnostics
Ford Hutman Media Announces the Promotion of Julia Fuller to Managing Partner
Fuller will help drive the growth and innovation of strategic communications firmCARLSBAD, Calif.--(BUSINESS WIRE)--#AppointmentNews--Ford Hutman Media (FHM), a media-savvy, senior...
GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process...
Massachusetts Governor, Senate President, Speaker of the House, Leaders of Legislature, Medicine, and Advocacy Lead the Nation in the Fight Against Prostate Cancer
AdMeTech Foundation's 15th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Medical Education, Research,...
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
The stenoparib Phase 2 monotherapy trial in advanced, recurrent ovarian cancer continues to show promise, prompting shift in resources...
BioSpy’s Prostate Cancer Screening Breakthrough Runs on Rymedi’s Blockchain-Enabled Clinical Diagnostics Platform
GREENVILLE, SC / ACCESSWIRE / March 26, 2024 / Rymedi is proud to announce its newest collaboration with BioSpy, the...
She Is Not Skipping a Beat, and Patients Are Noticing
NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Quest Diagnostics At Quest for 2 years, Marissa McGhee, Patient Services...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Proposed business combination to create a North American technology company with an AI-driven fintech marketplace. Combined company to apply for...
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time HENDERSON,...
GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health
GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations capabilitiesCHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC)...
Translational Vision Science and Technology Journal Publishes RadiusXR’s NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
PLEASANTON, Calif.--(BUSINESS WIRE)--#Ophthalmology--RadiusXR, the trailblazer in Digital Health, announces the publication of its groundbreaking NOVA Clinical Trial in Translational Vision...
Politan Nominates Two Independent Candidates for Masimo Board
Supports Strategic Review of Consumer Business, But Has Serious Concerns Given Masimo’s Broken Governance and Lack of Independent Oversight Nominees...
CMTA Board Evolution: Welcoming Bernard Coulie and Kevin Marks
Bernard Coulie and Kevin Marks bring significant corporate, drug development, and compliance experience to the CMTA BoardThe CMTA Board and...
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
Plus’ CSF-01 cancer cell enumeration test is a sensitive and specific diagnostic test for the presence of adenocarcinoma and melanoma...
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based...
GE HealthCare Announces Cash Dividend for First Quarter of 2024
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per...
GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024
Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases and health conditions Scientific studies...
Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners
Babson introduces BetterWay™ blood testing, which uses a pea-sized amount of blood collected from a finger to produce results equivalent...
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
VANCOUVER, BC / ACCESSWIRE / March 21, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...